Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cm 6912
2. Ethyl Flucozepate
3. Victan
1. Victan
2. Meilax
3. 29177-84-2
4. Ethyl Fluclozepate
5. Cm 6912
6. Loflazepic Acid, Ethyl Ester
7. Vjb5fw9w9j
8. Ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1h-1,4-benzodiazepine-3-carboxylate
9. 1h-1,4-benzodiazepine-3-carboxylic Acid, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, Ethyl Ester
10. Ethylis Loflazepas
11. Ethyl Loflazepate [inn:jan]
12. Loflazepate D'ethyle
13. Loflazepato De Etilo
14. Ethylis Loflazepas [inn-latin]
15. Loflazepate D'ethyle [inn-french]
16. Loflazepato De Etilo [inn-spanish]
17. Einecs 249-489-4
18. Unii-vjb5fw9w9j
19. Brn 0765264
20. Dea No. 2758
21. Meilax (tn)
22. Cm-6912
23. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate
24. 5-25-08-00124 (beilstein Handbook Reference)
25. Ethyl Loflazepate (jan/inn)
26. Schembl156702
27. Ethyl Loflazepate [mi]
28. Ethyl Loflazepate [inn]
29. Ethyl Loflazepate [jan]
30. Chembl1213460
31. Chebi:31573
32. Dtxsid60865475
33. Ethyl Loflazepate [mart.]
34. Ethyl Loflazepate [who-dd]
35. Db01545
36. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-1,4-benzodiazepine-3-carboxylate
37. D01293
38. Q5404460
39. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-1,4-benzodiazepine-3-carboxylate #
40. (e)-ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-benzo[e][1,4]diazepine-3-carboxylate
41. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-benzo[e][1,4]diazepine-3-carboxylate
Molecular Weight | 360.8 g/mol |
---|---|
Molecular Formula | C18H14ClFN2O3 |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 360.0676982 g/mol |
Monoisotopic Mass | 360.0676982 g/mol |
Topological Polar Surface Area | 67.8 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 556 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
N - Nervous system
N05 - Psycholeptics
N05B - Anxiolytics
N05BA - Benzodiazepine derivatives
N05BA18 - Ethyl loflazepate
ABOUT THIS PAGE
23
PharmaCompass offers a list of Ethyl Loflazepate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ethyl Loflazepate manufacturer or Ethyl Loflazepate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ethyl Loflazepate manufacturer or Ethyl Loflazepate supplier.
PharmaCompass also assists you with knowing the Ethyl Loflazepate API Price utilized in the formulation of products. Ethyl Loflazepate API Price is not always fixed or binding as the Ethyl Loflazepate Price is obtained through a variety of data sources. The Ethyl Loflazepate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Victan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Victan, including repackagers and relabelers. The FDA regulates Victan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Victan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Victan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Victan supplier is an individual or a company that provides Victan active pharmaceutical ingredient (API) or Victan finished formulations upon request. The Victan suppliers may include Victan API manufacturers, exporters, distributors and traders.
click here to find a list of Victan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Victan Drug Master File in Japan (Victan JDMF) empowers Victan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Victan JDMF during the approval evaluation for pharmaceutical products. At the time of Victan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Victan suppliers with JDMF on PharmaCompass.
Victan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Victan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Victan GMP manufacturer or Victan GMP API supplier for your needs.
A Victan CoA (Certificate of Analysis) is a formal document that attests to Victan's compliance with Victan specifications and serves as a tool for batch-level quality control.
Victan CoA mostly includes findings from lab analyses of a specific batch. For each Victan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Victan may be tested according to a variety of international standards, such as European Pharmacopoeia (Victan EP), Victan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Victan USP).